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Concise Report
Stiff skin syndrome: evidence for an inflammation-independent
fibrosis?
Serena Guiducci1,*, Joerg H. W. Distler2,*, Anna Franca Milia1, Irene Miniati1, Veronica Rogai1,
Mirko Manetti3, Fernanda Falcini4, Lidia Ibba-Manneschi3, Steffen Gay2, Oliver Distler2 and
Marco Matucci-Cerinic1
Objectives. Stiff skin syndrome (SSS) is a rare scleroderma-like syndrome of unknown aetiology. A 16-year-old boy presented with thoracic
and abdominal asymmetry, and ‘orange peel’ cutaneous lesions, with fibrotic stone-hard indurations at the buttocks, thighs and arms leading
to secondary joint contractures of the extremities. Our aim was to analyse the expression of extracellular matrix (ECM) molecules and
pro-fibrotic cytokines in the dermis and epidermis of SSS.
Methods. The diagnosis of SSS was confirmed by clinical and histopathological examination. Collagen type 1 alpha-2 chain (Col1A2),
fibronectin-1, thrombospondin-1, TGF-b, connective tissue growth factor (CTGF), IL-6, -1b, ET-1, Fibroblast growth factor receptor 3
(FGFR-3) and MCP-1 expression was analysed in SSS and age- and sex-matched healthy control skin by real-time PCR. VEGF expression
was also studied.
Results. Histopathological examination showed flattened dermal papillae, a scarce presence of sub-epidermal microvessels and mild dermal
fibrosis, but no inflammatory infiltrates. In the SSS dermis, the expression of IL-1b, -6 and MCP-1 was low, whereas VEGF was intensively
expressed. No differences were observed for TGF-b, CTGF and ET-1. In contrast, col1A2, fibronectin-1 and thrombospondin-1 were
overexpressed in the SSS dermis.
Conclusion. In our SSS patient, an overexpression of ECM proteins was detected, whereas no inflammatory infiltrates or up-regulation of
pro-fibrotic cytokines were found. The data suggest that fibrosis in SSS might be independent from inflammation.
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Introduction
Stiff skin syndrome (SSS) is clinically characterized by stone-hard
skin, leading to a secondary limitation of joint mobility. First
manifestations of SSS are usually observed between birth and
early childhood [1], and the disease progresses until the skin of
the entire body becomes fibrotic with subsequent growth retarda-
tion and joint contractures. Skin fibrosis can also lead to
decreased costo-vertebral joint mobility with restrictive changes
of lung function [1].
SSS was first described in 1968 in a boy with joint contractures
and skin changes resembling scleroderma [1] and, in 1971, in
four patients showing skin hardening and secondary limitation
of joint mobility [2]. Until now, about 30 SSS patients have
been described in the literature, with few familial cases [2–4].
The pathogenesis of SSS remains unknown. Initially, an abnormal
mucopolysaccharide metabolism limited to the skin, in absence of
mucopolysacchariduria, has been suggested [2]. Cutaneous lesions
in SSS were attributed to deposits of acid mucopolysaccharides
localized within collagen fibres in the dermis and hypodermis [1, 2,
5–7]. Recently, the most relevant modifications were localized in
the fascia, which was thickened by a hyalinized collagenous tissue
[3–6, 9]. In skin fibroblasts, collagen synthesis was up-regulated
as shown by increased activity of prolylhydroxylase and lysyl-
hydroxylase [9].
The aim of our study was to investigate, in a young boy
with SSS, the cutaneous histopathology and the expression of
extracellular matrix (ECM) molecules and pro-fibrotic cytokines
in order to provide new insights into the pathogenesis of this rare
disease.
Case report
A 16-year-old boy, born from healthy unrelated parents, was
referred to the Division of Rheumatology of the University of
Florence. No one in the family was affected by a similar or fibros-
ing disease. Medical history revealed that, on the second day after
delivery, he had developed severe icterus requiring ex-sanguinis
transfusion due to maternal–fetal incompatibility (ABO anti-A).
A reduced height–weight growth during the first year was
observed but blood tests including serum creatinine, transami-
nases, glucose and complete blood cell count were within
normal limits. Thyroid function was also normal and screening
for coeliac disease, arginine-stimulated growth hormone (GH)
concentration and metabolic tests were negative.
At 1 year of age, the baby developed thoracic and abdominal
asymmetry, and ‘orange peel’ cutaneous lesions mimicking eosi-
nophilic fascitis, with induration of the buttocks, thighs and arms.
Since then, the skin and the underlying tissues, progressively har-
dened leading to a reduced extension of the right elbow and both
legs.
At 4 years of age, a biopsy from the right thigh including
cutaneous and subcutaneous layers and muscle fascia, was taken
and showed dense fibrous thickened fascia, three to four times
the normal size with increased deposition of collagen. A mild
fibrosis of the deep portion of dermis retinacula and mild
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interstitial accumulation of mucopolysaccharides without
inflammatory infiltrates or vascular changes were observed.
ANAs, ENA antibodies and ACAs were negative and com-
plement fractions (C3 and C4) were normal. Oesophageal
and chest X-rays, nail-fold capillaroscopy, ophthalmological and
psychological evaluations were negative. Hand X-rays, at 8 years,
showed a skeletal age of 4 years.
When the patient was brought to our attention at an age of
16 years the most relevant sign was the stone-hard induration of
buttocks and thighs (Fig. 1A). The patient was not receiving any
pharmacological treatment. RP, sclerodactyly, fingertip ulcers and
dysphagia were not observed. The following tests were normal:
complete blood count, kidney and liver functional tests, ESR
(Westergren), CRP, C3 and C4, serum lysozyme, serum electro-
phoresis, serum hormonal estimations (pubertal values), routine
urine analysis, abdominal ultrasound and echocardiography.
Chest X-ray showed rib cage dysmorphism. Pulmonary function
tests revealed a mild reduction of forced vital capacity (FVC) (2.61
vs 3.93 predicted). Osteocalcin was increased to 93.3 ng/ml
(normal range 11.1–32.2 ng/ml). Dual X-ray of spinal column
at the lumbar level showed significant reduction of bone mass
with osteoporosis (T-score L4 2.74). No calcifications of soft
periarticular tissues were observed. ASMA, anti-microsomal,
anti-mitochondrial, ANA, anti-nDNA, ENA, ACA, aPL, anti-
thyroid (anti-TG, anti-TSH, anti-TPO) and anti-gastric mucosa
antibodies were negative. Nail-fold videocapillaroscopic exami-
nation did not reveal any significant alterations.
Despite generalized limitation of joint mobility, there was
no evidence of joint inflammation. The child showed difficulty
walking due to stiffness of the right lower limb. The clinical
features fulfilled the criteria for SSS proposed by Kikuchi [1]:
stiff skin, limitation of joint mobility without visceral involve-
ment and no increased amount of mucopolysacchariduria.
Hypertrichosis, skin atrophy, dental abnormalities, bone hypo-
plasia and knuckle pads were not detected in our patient.
Materials and methods
Sample collection
Full-thickness biopsies, approximately 3 0.5 cm, were obtained
from the clinically involved skin of the right femoral region of
the SSS patient. Skin biopsies were also obtained from the same
anatomical region of three age- and sex-matched healthy control
subjects, who underwent surgery for traumatic lesions. Each
biopsy was cut into two samples and processed for histological
analysis and real-time PCR. Biopsies were taken after informed
consent from parents and approval by the institutional review
board was obtained.
Histopathological analysis
For histopathological analysis, the specimens were fixed in 10%
buffered formalin and routinely processed for paraffin embedding.
Sections (5m thick) were processed for haematoxylin and eosin
(H&E), Masson’s trichrome and alcian blue stainings (Bio-Optica,
Milan, Italy). The stained sections were examined under a light
microscope (Eclipse E400; Nikon, Tokyo, Japan) and photo-
graphed with a digital camera (Coolpix 2500; Nikon).
Immunohistochemistry
Sections were de-waxed and heated in EDTA buffer (pH 8.0)
for antigen retrieval. After blocking endogenous peroxidase
activity and non-specific site binding, the sections were incubated
with a mouse monoclonal antibody against the panendothelial
marker von Willebrand factor (vWF; 1 : 50 dilution; Novocastra
Laboratories, Newcastle, UK). The immunoreactivity was
detected using biotinylated secondary antibodies and avidin–
biotin–peroxidase complex (UltraVision Detection System;
LabVision Corporation, Fremont, CA, USA), followed by
colour development using 3,30-diaminobenzidine tetrahydrochlor-
ide (Vector, Burlingame, CA, USA) as chromogen. Sections were
lightly counterstained with Mayer’s haematoxylin, and finally the
slides were mounted with Aquatex mounting medium (Merck,
Darmstadt, Germany). Normal isotype-matched IgG (Sigma,
St Louis, MO, USA) were used at the same concentration to
replace the primary antibody, as a negative staining control. The
stained sections were examined under a light microscope (Eclipse
E400). Three fields (40 magnification) from two random sections
of each biopsy were analysed by a blinded observer. In the
examined fields we performed a semiquantitative analysis of
vWF-positive blood vessels, considering the distinct areas such
as papillary dermis and reticular dermis. The score was defined
as follows: þþþ¼ plenty of vessels; þþ¼moderate presence of
vessels; þ¼ few vessels; þ/¼ very few vessels; ¼ hardly any
vessels, as described elsewhere [10].
Quantitative real-time PCR
In each biopsy, the epidermis was separated from the dermis for
better homogenization of the tissue samples and better com-
parability of the gene expression. For real-time PCR, total RNA
was reverse transcribed into cDNA with Random Hexamers
FIG. 1. (A) At the age of 16 years, the most relevant sign was the stone-hard skin
induration of only buttocks and thighs. (B) Negative alcian blue staining indicates
the absence of mucopolysaccharide deposits between collagen bundles in SSS
dermis (original magnification 40). (C, D) H&E staining of control (C) and SSS (D)
skin from the right femoral region (original magnification 20). No inflammatory
infiltrates are present in SSS dermis (D). (E, F) Masson’s trichrome staining of
control (E) and SSS (F) skin. Mild fibrosis and dense, tightly packed and irregularly
distributed collagen bundles are evident in SSS dermis (F) (original magnification
20). (G, H) Immunostaining for the panendothelial marker vWF in control (G) and
SSS (H) skin (blue haematoxylin counterstaining; original magnification 20).
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(Applied Biosystems, Rotkreuz, Switzerland). For quantification
of mRNA, SYBR Green real-time PCR [ET-1, connective tissue
growth factor (CTGF), IL-6, -1b, Fibroblast growth factor recep-
tor 3 (FGFR-3), TGF-b, collagen type 1 alpha-2 chain (col1A2),
fibronectin-1 and thrombospondin-1] or TaqMan real-time PCR
(MCP-1 and VEGF) was performed using the ABI Prism 7700
Sequence Detection System (Applied Biosystems). Specific
primer pairs for each gene were designed with the Primer
Express software (Applied Biosystems) as described elsewhere
[11–15]. Unspecific signals caused by primer dimers or genomic
DNA were excluded by dissociation curve analysis, no template
controls and samples without enzyme in the reverse transcription
(non-RT controls). A pre-developed b-actin assay (Applied
Biosystems) was used as an endogenous control to normalize for
the amounts of loaded cDNA. Differences were calculated with
the threshold cycle (Ct) and the comparative Ct method for
relative quantification. All measurements were performed in
duplicate.
Results
Analysis of fibrosis
Histopathological findings. The SSS skin showed flattened
dermal papillae, and absence of sebaceous glands (Fig. 1D) as
compared with control skin (Fig. 1C). In the dermis, tightly
packed and irregularly distributed collagen bundles were observed
with mild fibrosis, as shown by Masson’s trichrome staining
(Fig. 1E and F). Alcian blue staining was negative indicating
the absence of mucopolysaccharide deposits between collagen
bundles (Fig. 1B).
Quantitative real-time PCR. In the dermis, an overexpression
of col1A2, fibronectin and thrombospondin-1 was observed, while
in the epidermis none of these molecules was different from
controls. Interestingly, no difference was detected in the expres-
sion of pro-fibrotic mediators (TGF-b, ET-1 and CTGF) both in
the epidermis and in the dermis (Table 1).
Analysis of microvessels
Histopathological findings. A loss of sub-epidermal microves-
sels (þ) (Fig. 1G and H) was detected when compared with
healthy skin, where microvessels are largely present (þþþ). In
the reticular dermis, a regular distribution and presence of
blood vessels were observed (þþþ).
Quantitative real-time PCR. In the dermis, VEGF was
increased in respect to control, while in the epidermis it did not
show any difference (Table 1).
Analysis of inflammation
Histopathological findings. No inflammatory infiltrates were
detected in the SSS dermis (Fig. 1D).
Quantitative real-time PCR. This analysis showed a different
pattern between epidermis and dermis as IL-6, -1b, FGFR-3 and
MCP-1 were normally expressed in the epidermis, but down-
regulated in the dermis (Table 1).
Discussion
In the SSS dermis, the present study clearly showed an increase of
fibrotic molecules (col1A2, fibronectin-1 and thrombospondin-1)
and the presence of irregularly distributed collagen bundles,
flattening of dermal papillae and absence of sebaceous glands.
Inflammatory mediators (IL-6, -1b, FGFR-3 and MCP-1)
were down-regulated in agreement with the absence of dermal
inflammatory infiltrates. No differences in pro-fibrotic cytokines
(TGF-b, ET-1 and CTGF) were detected. In a previous work,
circulating levels of pro-inflammatory cytokines (IL-6, TNF-
and TGF-b2), were found to be increased, whereas collagen
production and DNA biosynthesis were normal [16]. These
differences to our findings might be explained by the different
methodological approach. In fact, assessment of these factors in
the skin might be more relevant for the pathogenesis of the
disease, as serum circulating levels are influenced by a large
number of confounding factors. However, different disease
stages might also account for controversial results.
Up to date, about 30 cases of SSS have been described in the
literature, but the pathogenesis remains still unknown. Usually,
SSS is a diagnosis of exclusion, with a distinctive clinical presenta-
tion but no pathognomonic laboratory or pathological findings.
The clinical differential diagnosis of stone-hard and thickened
skin areas includes SSc, sclerodema, eosinophilic fasciitis
and scleromyxoedema. The appearance of the disease in early
childhood, the limitation of joint mobility, the proximal rather
than a distal stiffness and the absence of organ involvement are
the main clinical findings that differentiate SSS from SSc [7, 17].
Moreover, microvascular abnormalities, RP and autoantibodies
were absent in SSS [18]. However, in our SSS patient, a loss of
microvessels was clearly evident at the dermal–epidermal junction
and in the papillary dermis, despite the overexpression of VEGF
found in the dermis.
SSS is a non-progressive cutaneous disease and involves mostly
the buttocks, the trunk and thighs, and does not show increased
deposition of acid-mucopolysaccharides in the dermis [16].
In agreement with other authors [16], our data did not show
mucopolysaccharide deposits in the dermis. However, Geng
et al. [18] reported mild deposits of mucopolysaccharides between
the collagen bundles throughout the dermis, hypothesizing that
SSS could be a localized form of mucopolysaccharidosis [2].
Notably, our patient had no exposure to chemical substances
or drugs that have been implicated in the pathogenesis of pseudo-
scleroderma [19].
The similarity between SSS and the alterations in collagen
metabolism has been put forward in the model of the tight-skin
mouse (Tsk-1) [5]. However, the literature remains controversial
about the collagen production, as cultured fibroblasts of SSS or of
Tsk-1 mice were normal [5], but also revealed an abnormal
production of collagen [9]. Our data clearly support the concept
of an increased collagen and ECM production in the dermis as
shown by quantitative real-time PCR. Richard et al. [16] proposed
that a primary fibroblast defect or a fascial abnormality needs to
be ruled out in this disease. Recently, Liu et al. [4] found areas of
fascial sclerosis or increased fibroblast cellularity with thickened
and sclerotic collagen bundles without associated inflammation.
In our case, pro-inflammatory mediators such as IL-1b and -6
involved in the regulation of dermal fibrosis, were down-regulated
in the dermis, suggesting that fibrosis in SSS might be independent
from an inflammatory process.
TABLE 1. Quantitative real-time PCR results
MCP-1 VEGF ET-1 IL-1b TGF-b CTGF Col1A2 FGFR-3 IL-6 Fibronectin-1 Thrombospondin-1
Epidermis 1.03 1.4 0.76 0.05 0.95 1.13 1.05 0.86 0.98 1.5 0.7
Dermis 0.26 3.31 1.39 0.29 1.4 1.42 11.39 0.18 0.11 4.1 5
The value in SSS is represented as x-fold increased or decreased vs control assumed¼ 1.
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In conclusion, our results suggest that the fibrotic process in
SSS might be independent from local inflammation. However, it
should be considered that our observations were performed on an
SSS patient with long-standing disease, and therefore need to be
confirmed in early disease stages. If these findings are confirmed
in larger sample numbers, they have direct implications on
therapeutic approaches in these patients, as unspecific immuno-
suppressive treatments are unlikely to be successful in these
patients. Future investigations should focus on the dermis, and
in particular on ECM components such as collagen fibres and
microfibril metabolism. Further studies are warranted to clarify,
at different disease stages, the factors involved in the development
of dermal fibrosis in SSS.
Rheumatology key messages
 In our SSS case, ECM proteins were overexpressed, whereas no
inflammatory infiltrates or pro-fibrotic cytokine up-regulation was
found.
 Fibrosis in SSS might be independent from local inflammation.
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